Serum-free in vitro bioassay for the detection of tumor necrosis factor - PubMed (original) (raw)
Serum-free in vitro bioassay for the detection of tumor necrosis factor
S M Kramer et al. J Immunol Methods. 1986.
Abstract
A sensitive, reproducible in vitro bioassay is described for quantitating the cytolytic activity of tumor necrosis factor (TNF). The assay target cells, murine connective tissue L-M, are propagated and the assay performed under serum-free conditions. The quantitation of cytolytic activity is based on the ability of TNF to lyse L-M cells in the presence of actinomycin D, as measured by crystal violet dye uptake of residual viable cells. The assay is sensitive to 88 pg/ml TNF-alpha. The simplicity of the culture medium combined with high sensitivity and low variability make this a particularly well-suited bioassay for routine detection of TNF cytolytic activity.
Similar articles
- Comparison of TNF-alpha and TNF-beta cytolytic biological activities in a serum-free bioassay.
Kramer SM, Carver ME, Apperson SM. Kramer SM, et al. Lymphokine Res. 1986;5 Suppl 1:S139-43. Lymphokine Res. 1986. PMID: 3784609 - A specific and reliable bioassay for the detection of femtomolar levels of human and murine tumor necrosis factors.
Branch DR, Shah A, Guilbert LJ. Branch DR, et al. J Immunol Methods. 1991 Oct 25;143(2):251-61. doi: 10.1016/0022-1759(91)90050-p. J Immunol Methods. 1991. PMID: 1940393 - Optimization of the L-M cell bioassay for quantitating tumor necrosis factor alpha in serum and plasma.
Nargi FE, Yang TJ. Nargi FE, et al. J Immunol Methods. 1993 Feb 26;159(1-2):81-91. doi: 10.1016/0022-1759(93)90144-v. J Immunol Methods. 1993. PMID: 8445267 - Fluorescence microplate-based assay for tumor necrosis factor activity using SYTOX Green stain.
Jones LJ, Singer VL. Jones LJ, et al. Anal Biochem. 2001 Jun 1;293(1):8-15. doi: 10.1006/abio.2001.5116. Anal Biochem. 2001. PMID: 11373072 - Improved fluorescent bioassay for the detection of tumor necrosis factor activity.
Lévesque A, Paquet A, Pagé M. Lévesque A, et al. J Immunol Methods. 1995 Jan 13;178(1):71-6. doi: 10.1016/0022-1759(94)00243-p. J Immunol Methods. 1995. PMID: 7829867
Cited by
- Development of partial tolerance to the gastrointestinal effects of high doses of recombinant tumor necrosis factor-alpha in rodents.
Patton JS, Peters PM, McCabe J, Crase D, Hansen S, Chen AB, Liggitt D. Patton JS, et al. J Clin Invest. 1987 Dec;80(6):1587-96. doi: 10.1172/JCI113245. J Clin Invest. 1987. PMID: 3500186 Free PMC article. - Involvement of endogenous tumor necrosis factor alpha and transforming growth factor beta during induction of collagen type II arthritis in mice.
Thorbecke GJ, Shah R, Leu CH, Kuruvilla AP, Hardison AM, Palladino MA. Thorbecke GJ, et al. Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7375-9. doi: 10.1073/pnas.89.16.7375. Proc Natl Acad Sci U S A. 1992. PMID: 1502148 Free PMC article. - The protective effect of FK506 pretreatment against renal ischemia/reperfusion injury in rats.
Sakr M, Zetti G, McClain C, Gavaler J, Nalesnik M, Todo S, Starzl T, Van Thiel D. Sakr M, et al. Transplantation. 1992 May;53(5):987-91. doi: 10.1097/00007890-199205000-00004. Transplantation. 1992. PMID: 1374948 Free PMC article. - Nitric oxide synthase inhibition results in synergistic anti-tumour activity with melphalan and tumour necrosis factor alpha-based isolated limb perfusions.
de Wilt JH, Manusama ER, van Etten B, van Tiel ST, Jorna AS, Seynhaeve AL, ten Hagen TL, Eggermont AM. de Wilt JH, et al. Br J Cancer. 2000 Nov;83(9):1176-82. doi: 10.1054/bjoc.2000.1447. Br J Cancer. 2000. PMID: 11027431 Free PMC article. - In vivo isolated kidney perfusion with tumour necrosis factor alpha (TNF-alpha) in tumour-bearing rats.
van der Veen AH, Seynhaeve AL, Breurs J, Nooijen PT, Marquet RL, Eggermont AM. van der Veen AH, et al. Br J Cancer. 1999 Feb;79(3-4):433-9. doi: 10.1038/sj.bjc.6690067. Br J Cancer. 1999. PMID: 10027309 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources